NEUROSENSE THERAPEUTICS LTD (NRSN) Stock Cash Flow
NASDAQ:NRSN - IL0011809592 - Common Stock
1.06 USD
-0.08 (-7.02%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.66M | -10.21M | -11.28M | -12.34M | -4.04M | |||
| Depreciation Amortization | 19.00K | 22.00K | 21.00K | 90.00K | 0.00 | |||
| Change In Working Capital | -297.00K | -781.00K | 1.91M | 730.00K | 270.00K | |||
| Other non cash items | 551.00K | 834.00K | -181.00K | 3.94M | 2.23M | |||
| OPERATING CASH FLOW | -8.38M | -10.13M | -8.35M | -7.59M | -1.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.00K | -3.00K | -29.00K | -70.00K | -20.00K | |||
| Other Investing Activity | -8.00K | 4.00K | 3.50M | -3.47M | 0.00 | |||
| INVESTING CASH FLOW | -13.00K | 1.00K | 3.47M | -3.54M | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | -80.00K | -80.00K | N/A | |||
| Stock Issued/Repurchased | 8.28M | 11.30M | 4.34M | 3.87M | 11.10M | |||
| Other Financing Activity | -378.00K | -391.00K | -364.00K | -100.00K | 800.00K | |||
| FINANCING CASH FLOW | 7.90M | 10.91M | 3.98M | 3.70M | 11.90M | |||
| Exchange Rate Effect | -41.00K | -41.00K | 8.00K | -90.00K | 20.00K | |||
| CHANGE IN CASH | -542.00K | 738.00K | -903.00K | -7.52M | 10.36M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.38M | -10.13M | -8.35M | -7.59M | -1.54M | |||
| Capital Expenditure | -5.00K | -3.00K | -29.00K | -70.00K | -20.00K | |||
| FREE CASH FLOW | -8.39M | -10.14M | -8.38M | -7.66M | -1.56M | |||
All data in USD